Janus Henderson Group’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$360M Sell
6,738,556
-330,092
-5% -$17.6M 0.18% 125
2025
Q1
$302M Buy
7,068,648
+1,034,409
+17% +$44.2M 0.17% 142
2024
Q4
$168M Sell
6,034,239
-1,043,239
-15% -$29M 0.09% 211
2024
Q3
$203M Buy
7,077,478
+201,225
+3% +$5.77M 0.1% 189
2024
Q2
$161M Buy
6,876,253
+754,283
+12% +$17.7M 0.09% 201
2024
Q1
$155M Buy
6,121,970
+1,815,569
+42% +$45.8M 0.08% 211
2023
Q4
$101M Sell
4,306,401
-180,325
-4% -$4.21M 0.06% 250
2023
Q3
$227M Buy
4,486,726
+61,607
+1% +$3.12M 0.15% 154
2023
Q2
$207M Buy
4,425,119
+613,443
+16% +$28.6M 0.13% 162
2023
Q1
$146M Buy
3,811,676
+471,502
+14% +$18M 0.1% 201
2022
Q4
$183M Sell
3,340,174
-5,210,744
-61% -$286M 0.13% 172
2022
Q3
$291M Buy
8,550,918
+5,482,606
+179% +$187M 0.11% 196
2022
Q2
$29M Sell
3,068,312
-300,350
-9% -$2.84M 0.02% 506
2022
Q1
$47.8M Buy
3,368,662
+205,040
+6% +$2.91M 0.02% 512
2021
Q4
$66.9M Sell
3,163,622
-71,365
-2% -$1.51M 0.03% 459
2021
Q3
$72.3M Sell
3,234,987
-252,508
-7% -$5.64M 0.03% 449
2021
Q2
$86.5M Buy
3,487,495
+4,830
+0.1% +$120K 0.04% 420
2021
Q1
$101M Sell
3,482,665
-10,754
-0.3% -$312K 0.05% 368
2020
Q4
$90.1M Sell
3,493,419
-42,036
-1% -$1.08M 0.04% 389
2020
Q3
$109M Buy
3,535,455
+796,937
+29% +$24.5M 0.06% 307
2020
Q2
$68.2M Sell
2,738,518
-28,302
-1% -$705K 0.04% 412
2020
Q1
$58.7M Buy
2,766,820
+357,287
+15% +$7.57M 0.04% 415
2019
Q4
$53.5M Buy
2,409,533
+379,505
+19% +$8.42M 0.03% 567
2019
Q3
$44.6M Buy
2,030,028
+1,268,875
+167% +$27.9M 0.02% 610
2019
Q2
$14.6M Buy
+761,153
New +$14.6M 0.01% 865